Form 4: Palomar CFO Uchida Reports RSU Vesting & Tax Sales

Sentiment:

Insider Transaction Report


Palomar Holdings, Inc. CFO T Christopher Uchida reported the vesting of Restricted Stock Units and subsequent sell-to-cover transactions for tax obligations in late January 2026.

Summary

  • Chief Financial Officer T Christopher Uchida of Palomar Holdings, Inc. reported multiple transactions involving Restricted Stock Units (RSUs) on January 29 and January 31, 2026.
  • A total of 4,403 shares of common stock vested from RSU grants on these dates.
  • Concurrently, 1,871 shares were automatically sold to cover minimum statutory tax withholding obligations related to these RSU vesting events.
  • The shares sold for tax purposes were executed at prices of $122.0423, $122.0435, and $121.7443.
  • Following these transactions, Uchida's direct beneficial ownership of Palomar Holdings common stock stands at 14,005 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing a routine executive compensation transaction involving RSU vesting and mandatory tax-related share sales, with no significant positive or negative implications for the company's operational or financial performance.

Positives

  • Vesting of 4,403 Restricted Stock Units indicates continued service and compensation for the Chief Financial Officer.
  • The transactions demonstrate the company's ongoing executive compensation program, aligning executive interests with shareholder value through equity awards.

Negatives

  • A total of 1,871 shares were sold, reducing the CFO's direct beneficial ownership, although this was a mandatory sell-to-cover for tax purposes rather than a discretionary sale.

Future Outlook

The RSU grant schedules indicate future vesting events for the reporting person, contingent on continued service with Palomar Holdings, Inc., suggesting ongoing executive retention and alignment with long-term company performance.

Industry Context

StockSavvy.ai notes that routine insider transaction reports like this Form 4 are common disclosures for publicly traded companies, reflecting standard executive compensation practices involving equity awards and mandatory tax withholdings upon vesting. These transactions are typically not indicative of broader industry trends but rather specific company compensation structures.

Stakeholder Impact

  • Minimal impact on shareholders as these are routine executive compensation transactions and mandatory tax-related sales, not discretionary sales indicating a change in management's confidence or a shift in company strategy.

Next Steps

  • Future vesting of remaining RSU grants from January 29, 2024, on their second and third-year anniversaries.
  • Future vesting of remaining RSU grants from January 29, 2025, on their second and third-year anniversaries.
  • Future vesting of remaining RSU grants from January 31, 2023, on its third-year anniversary.

Key Dates

DateDescription
01/31/2023Original RSU grant of 3,162 shares, vesting one-third annually over three years.
01/29/2024Original RSU grant of 4,226 shares, vesting one-third annually over three years.
01/29/2025Original RSU grant of 5,823 shares, vesting one-third annually over three years.
01/29/2026Vesting of 1,408 and 1,941 Restricted Stock Units; subsequent sell-to-cover of 511 and 815 shares for tax obligations.
01/31/2026Vesting of 1,054 Restricted Stock Units; subsequent sell-to-cover of 545 shares for tax obligations.
02/02/2026Date of filing by Attorney-in-Fact.

Keywords

Palomar Holdings, PLMR, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, CFO, Executive Compensation, Stock Sale, Tax Withholding

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.